Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
A rare ophthalmic disorder characterized by typically bilateral, asymmetric, yellowish, punctate chorioretinal lesions of the posterior pole forming a linear branching pattern and progressing to atrophic scars. Subretinal neovascular membranes occur in many cases. Vitritis is always absent. Patients may present with blurred vision, scotoma, floaters, photopsia, and metamorphopsia. Choroidal neovascular membrane formation and subretinal fibrosis are the major causes of visual loss. The condition predominantly occurs in young myopic females.
Biomarker and diagnostic research for punctate inner choroidopathy has been reported in the published literature.
No clinical trials have been registered for punctate inner choroidopathy.
44 publications have been identified in PubMed for punctate inner choroidopathy. Research spans Case Report / Case Series (41%), Review / Meta-Analysis (20%), and Epidemiology / Natural History (16%).
Research Type | Count | % of Total |
|---|---|---|
Patient case studies | 18 | 41% |
Data assembled from 3 of 12 sources · Last updated Sep 19, 2026, 12:48 AM UTC
European rare disease database
Genetic and Rare Diseases Info Center
Research summaries
9 |
20% |
Disease patterns and progression | 7 | 16% |
Testing and diagnosis research | 6 | 14% |
Clinical study results | 2 | 5% |
Laboratory research | 2 | 5% |
Trinco A (2026). [PMID: 42191103](https://pubmed.ncbi.nlm.nih.gov/42191103/). *Am J Ophthalmol*. [Diagnostic / Biomarker]
Cicinelli MV (2026). [PMID: 41271025](https://pubmed.ncbi.nlm.nih.gov/41271025/). *Am J Ophthalmol*. [Epidemiology / Natural History]
Yang R (2026). [PMID: 41429400](https://pubmed.ncbi.nlm.nih.gov/41429400/). *Photodiagnosis Photodyn Ther*. [Basic Science / Preclinical]
Feo A (2026). [PMID: 41490810](https://pubmed.ncbi.nlm.nih.gov/41490810/). *Am J Ophthalmol*. [Review / Meta-Analysis]
Ferro Desideri L (2026). [PMID: 41109470](https://pubmed.ncbi.nlm.nih.gov/41109470/). *Am J Ophthalmol*. [Epidemiology / Natural History]
Sheth N (2026). [PMID: 42017868](https://pubmed.ncbi.nlm.nih.gov/42017868/). *Ophthalmol Retina*. [Case Report / Case Series]
Del Fabbro S (2026). [PMID: 41139068](https://pubmed.ncbi.nlm.nih.gov/41139068/). *Ophthalmology*. [Epidemiology / Natural History]
Bai J (2026). [PMID: 41790663](https://pubmed.ncbi.nlm.nih.gov/41790663/). *Medicine (Baltimore)*. [Case Report / Case Series]
Mount GR (2026). [PMID: 32491777](https://pubmed.ncbi.nlm.nih.gov/32491777/). *Unknown Journal*. [Diagnostic / Biomarker]
Belletti M (2026). [PMID: 41417717](https://pubmed.ncbi.nlm.nih.gov/41417717/). *Ocul Immunol Inflamm*. [Review / Meta-Analysis]